BNET Industries

Market Cap:$14.3B
Last Fiscal Year Sales:$3.9B
  • Public
  • US
Dow Jones Description

We are a multi-specialty health care company focused on developing and commercializing innovative pharmaceuticals, biologics and medical devices that enable people to see more clearly, move more freely and express themselves more fully. Our diversified approach enables us to follow our research and development into new specialty areas where unmet needs are significant. We discover, develop and commercialize specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries around the world. We are a pioneer in specialty pharmaceutical research, targeting products and technologies related to specific disease areas such as chronic dry eye, glaucoma, retinal disease, psoriasis, acne, movement disorders, neuropathic pain and genitourinary diseases. Our diversified business model includes products for which consumers may be eligible for reimbursement and cash pay products that consumers pay for directly. Based on internal information and assumptions, we estimate that in fiscal year 2008, approximately 70% of our net product sales were derived from reimbursable products and 30% of our net product sales were derived from cash pay products. ...

Chief Executive OfficerDavid E.I. Pyott
Number of Employees 8,740
Contact Information

2525 Dupont Dr

Irvine, California 92612-1531

allergan.com

(714) 246-4500

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Spectrum Pharma's Date With FDA

    6/25/09 - Joint Venture / Alliance - View Story

  • Buckingham Research Maintains a 'Strong Buy' on Allergan AGN; Accumulate Shares Despite FDA Delay

    5/27/09 - Bond / Stock Rating - View Story

  • Four Biotech Stocks with 'Free' Pipelines

    5/14/09 - Joint Venture / Alliance - View Story

  • SkinMedica signs co-promotion agreement with Allergan

    5/13/09 - Joint Venture / Alliance - View Story

  • New Natrelle® Pre-Consultation Kit Offers Breast Implant Trial for Cosmetic Surgery Patients

    5/05/09 - Product Announcement - View Story

  • BUYINS.NET: CVX, AOC, AGN, KDN, TRP and HMSY Expected To Be

    5/01/09 - Joint Venture / Alliance - View Story

  • Allergan Q1 net earnings decrease

    5/05/09 - Financial Announcement - View Story

  • BRIEF-Credit Suisse revises targets on U.S. specialty pharmaceutical cos

    4/20/09 - Bond / Stock Rating - View Story

  • Miracle worker knew his path since 3rd grade

    4/28/09 - Board Member - Entering - View Story

  • Allergan Acquires Irvine Office Bldg. for $21.8M

    4/15/09 - Buildings Purchased - View Story

  • Allergan "hold," target price raised

    4/15/09 - Bond / Stock Rating - View Story

  • Fitch Revises Allergan's Rating Outlook to Stable; Affirms IDR at 'A-'

    3/31/09 - Bond / Stock Rating - View Story

  • Fitch Revises Allergan's Rating Outlook to Stable; Affirms IDR at 'A-'

    3/31/09 - Bond / Stock Rating - View Story

  • William Blair Initiates Coverage on Allergan AGN

    3/17/09 - Bond / Stock Rating - View Story

  • Marcial: Allergan: A Lift from More Than Botox?

    2/25/09 - Bond / Stock Rating - View Story

  • Boehringer decision may cost Inspire Pharmaceuticals

    2/12/09 - Licensing / Contract - View Story

News & Analysis

allergan inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
David E.I. Pyott Chief Executive Officer
Dawn Hudson President and Chief Executive Officer of Pepsi, Cola North America
Michael R. Gallagher Chief Executive Officer
Michael Ball President
Douglas S. Ingram Chief Administrative Officer
Jeffrey L. Edwards Chief Financial Officer
Martin A. Voet Senior Vice President, Chief Intellectual Property Counsel & Assistant Secretary
Dianne Dyer-Bruggeman Executive Vice President, HR
Jacqueline Schiavo Executive Vice President, Global Technology Operations
Raymond H. Diradoorian Executive Vice President, Global Technical Operations
Roy Wilson Executive Vice President, Human Resources and Information Technology
Scott M. Whitcup Executive Vice President, Research and Development
James M. Hindman Senior Vice President, Treasury, Risk & Investor Relations
John R. Gibson Senior Vice President
Joshua Ofman Vice President, Reimbursement & Payment Policy
Julian Gangolli Corporate Vice President
Nelson R.A. Marques Vice President
Glenn E. Davis Partner
Thomas Albright Senior Director, Marketing, Botox
Donna M Norton Manager
James F. Barlow Senior Vice President, Corp. Controller (Pao)
Adam N Summers Investigator
Andrew Michael Blumenfeld Consultant
Bradley Calobrace Lecturer
Irina Abovsky-Akkerman Facial Rejuvenation Injection Trainer
Jamie Sherrill Trainer
Marina I Peredo National Education Faculty Trainer
Mark Ballentyne Trainer
Mary P Lupo Clinical Instructor
Matthew J. Maletta Assistant Secretary
R Samuel Bryant Principal Investigator
Stacy Vencill Trainer
Thomas Kislan Consultant
Deborah Dunsire Director
Gavin S. Herbert Director
Leonard D. Schaeffer Director
Stephen J. Ryan Director
Trevor M. Jones Director

Board of Directors

Name (plus bio) Position
Russell T. Ray Chairperson
Herbert W. Boyer Vice Chairman
Karen R. Osar Board of Directors
Louis J. Lavigne Jr. Board of Directors
Louis T. Rosso Board of Directors
Robert A Ingram Board of Directors
William R. Grant Board Member
Organization Position Status
Allergan, Inc. Chief Executive Officer Current
Allergan, Inc. President Current
Allergan, Inc. Chairman Current
Pacific Mutual Holding Company Director Current
Edwards Lifesciences Corporation Director Current
Allergan, Inc. Director Current
California Healthcare Institute, Inc. Director Current
Pacific Life Insurance Company Board of Directors Current
Cosmetic Surgery Foundation, Inc Board Member Current
University of California Director Current
Avery Dennison Corporation Director Current
Biotechnology Industry Organization Board Member Current
Pacific LifeCorp Director Current
IHOP Corp. Chief Executive Officer Former
Novartis AG President, Executive Committee Former
IHOP Corp. President Former
IHOP Corp. Chief Operating Officer Former
Sandoz Strategic Planning and In Marketing Former
Novartis AG Head of the Novartis Nutrition Division Former
Novartis AG Board of Directors Former
London Business School M.B.A. Former
University of Edinburgh M.A. Former
Novartis AG Executive Committee Member Former
Avery Dennison Corporation member Former
Organization Position Status
Allergan, Inc. President and Chief Executive Officer of Pepsi, Cola North America Current
Lgpa Chairperson of the Board Current
LPGA Chairperson of the Board Current
Allergan, Inc. Board of Directors Current
Organization Position Status
Allergan, Inc. Chief Executive Officer Current
University of California Member, Board of Advisors Current
Allergan, Inc. Director Current
St. Luke's School Board of Directors Current
Eastman Kodak Company Chief Executive Officer Former
Sterling Drug Chief Executive Officer Former
Sterling Drug President Former
Eastman Kodak Company President Former
Playtex Ltd. Former

Mr. Ball has been President since February 2006. Mr. Ball joined Allergan in 1995, and served as Executive Vice President and President, Pharmaceuticals, since October 2003. Born in Canada, Mr. Ball was educated in the United Kingdom and United States before receiving his Bachelor of Science and Master of Business Administration degrees from Queen's University in Canada. He is the former President of Syntex Inc. Canada and Senior Vice President of Syntex Laboratories USA, where he served on Syntex Corporation's Management Committee. Mr. Ball has more than 26 years of international health care experience in the marketing and sale of pharmaceutical products.

Organization Position Status
Allergan, Inc. President Current
Allergan, Inc. Senior Vice President Current
Meritech Capital Partners Board Member Current
Stradling Yocca Carlson & Rauth Board Member Current
American Surgisite Centers, Inc. Board Member Current
Eli Lilly and Company Former
Queens University M.B.A. Former
Queens University Bachelor of Science Degree Former

Mr. Ingram has been Executive Vice President, Chief Administrative Officer, General Counsel and Secretary since October 2006. From October 2003 to October 2006, Mr. Ingram served as Executive Vice President, General Counsel and Secretary. Mr. Ingram joined Allergan from Gibson, Dunn & Crutcher in 1996. Mr. Ingram has more than 19 years of experience in the management of domestic and international legal affairs. Mr. Ingram manages Allergan's Global Legal Affairs, Global Regulatory Affairs, Compliance and Internal Audit, Corporate Communications, Global Trade Compliance, Global Human Resources and Information Technology organizations. Mr. Ingram is the Secretary to Allergan's Board of Directors. Mr. Ingram received his Juris Doctorate from the University of Arizona in 1988, graduating summa cum laude and Order of the Coif.

Organization Position Status
Allergan, Inc. Chief Administrative Officer Current
Allergan, Inc. Secretary Current
Volcom, Inc. Board of Directors Current
Allergan, Inc. Executive Vice President Former
Allergan, Inc. Senior Vice President Former
Allergan, Inc. Corporate Vice President Former
Gibson, Dunn & Crutcher LLP NA Former
Allergan, Inc. General Counsel Former
The University of Arizona Juris Doctorate Former
Arizona State University B.A. Former
The University of Arizona Degree Former

Mr. Edwards has been Executive Vice President, Finance and Business Development, Chief Financial Officer, since September 2005. Mr. Edwards joined Allergan in 1993. From March 2003 to September 2005, Mr. Edwards served as Corporate Vice President, Corporate Development and previously served as Senior Vice President, Treasury, Tax and Investor Relations. Prior to joining Allergan, Mr. Edwards was with Banque Paribas and Security Pacific National Bank, where he held various senior-level positions in the credit and business development functions. Mr. Edwards completed the Advanced Management Program at the Harvard Business School and received a Bachelor of Arts degree in Sociology from Muhlenberg College.

Organization Position Status
Allergan, Inc. Chief Financial Officer Current
Allergan, Inc. Executive Vice President, Finance and Business Development Former
Security Pacific National Bank NA Former
Muhlenberg College Bachelor of Arts Degree In Sociology Former
Harvard Business School Advanced Management Program Former
Organization Position Status
Allergan, Inc. Senior Vice President, Chief Intellectual Property Counsel & Assistant Secretary Current
Organization Position Status
Allergan, Inc. Executive Vice President, HR Current
Broadcom Korea Senior Vice President, Global Human Resources Current
Broadcom Korea Vice President of Human Resources Current
Broadcom Corporation Senior Vice President, Global Human Resources Former
Titan Corporation Vice President, Human Resources Former
Broadcom Corporation Vice President of Human Resources Former
Tribune Company Director of Human Resources Former
Chicago Sun Times Manager Former
Titan Corporation Consultant Former
Ithaca College B.A. In Language Former
Organization Position Status
Allergan, Inc. Executive Vice President, Global Technology Operations Current
Pepperdine University M.B.A. Former
Cornell University bachelor of science degree in microbiology Former

Mr. Diradoorian has been Executive Vice President, Global Technical Operations, since February 2006. From April 2005 to February 2006, Mr. Diradoorian served as Senior Vice President, Global Technical Operations. Since February 2001, Mr. Diradoorian served as Vice President, Global Engineering and Technology. Mr. Diradoorian joined Allergan in July 1981. Prior to joining Allergan, Mr. Diradoorian held positions at American Hospital Supply and with the Los Angeles Dodgers baseball team. Mr. Diradoorian received a Bachelor of Science degree in Biological Sciences from the University of California, Irvine and a Master of Science degree in Technology Management from Pepperdine University.

Organization Position Status
Allergan, Inc. Executive Vice President, Global Technical Operations Current
S.Com, Inc. Executive Vice President, Global Technical Operations Former
Pepperdine University Master of Science Degree In Technology Management Former
American Hospital Supply Corporation Former
Pepperdine University M.S. Degree In Technology Management Former
University of California B.S. Degree In Biological Sciences Former
University of California, Irvine B.S. degree in Biological Sciences Former
Organization Position Status
Allergan, Inc. Executive Vice President, Human Resources and Information Technology Current
Mydials Inc. Executive, Russell Reynolds Current
Texchange Director Current
The University of Houston Director Current
Texas A&M University Director Current
BMC Software, Inc. Senior Vice President, Human Resources and Administration Former
Syracuse University bachelor of science degree Former

Dr. Whitcup has been Executive Vice President, Research and Development, since July 2004. Dr. Whitcup joined Allergan in 2000. Prior to joining Allergan, Dr. Whitcup served as the Clinical Director of the National Eye Institute at the National Institutes of Health. As Clinical Director, Dr. Whitcup's leadership was vital in building the clinical research program and developing new therapies for ophthalmic diseases. Dr. Whitcup graduated from Cornell University and Cornell University Medical College. He completed residency training in internal medicine at the University of California, Los Angeles and in ophthalmology at Harvard University, as well as fellowship training in immunology at the National Institutes of Health. Dr. Whitcup is a faculty member at the Jules Stein Eye Institute/David Geffen School of Medicine at the University of California, Los Angeles.

Organization Position Status
Allergan, Inc. Executive Vice President, Research and Development Current
National Institutes of Health Clinical Director Former
National Eye Institute Clinical Director Former
Nei, Inc. Former
Cornell University Graduate Former
Weill Medical College of Cornell University Graduate Former
Organization Position Status
Allergan, Inc. Senior Vice President, Treasury, Risk & Investor Relations Current

John R. Gibson, MBChB, MRCP (UK), FRCP (Glasgow) is the Senior Vice President, Global Development at Allergan, Irvine, California. He also serves as Volunteer Clinical Professor of Dermatology, UCI, Irvine, California, and SUNY, Buffalo, New York. He received his medical degree from Glasgow University in 1973, and subsequently trained in general medicine, infectious diseases and pediatrics in Zimbabwe and the United Kingdom. Development as a Dermatologist occurred in parallel with an industry career. He was appointed Honorary Consultant Dermatologist at the Royal London Hospital, England in 1982. He has significant international (27 years) experience in all aspects of drug development with three major pharmaceutical companies (Wellcome, Bristol-Myers Squibb and Allergan); and a track record of product approvals worldwide in the fields of dermatology, ophthalmology and neurology, with additional experience in oncology, allergy and anti-infectives, including anti-virals. His passion for drug development and medicine remains powerfully intact.

Organization Position Status
Allergan, Inc. Senior Vice President Current
Ventana Capital Management, LLC Pharmaceutical Industry Advisor Current
Bristol-Myers Squibb Company Current
British-American Business Council Member of the Board of Directors Current
Somanta Limited Director Current
State University of New York at Buffalo Volunteer Former
Glasgow University Medical Degree Former
Organization Position Status
Allergan, Inc. Vice President, Reimbursement & Payment Policy Current
Organization Position Status
Allergan, Inc. Corporate Vice President Current
The Armenian Eyecare Project Board of Directors Current
The Glaucoma Foundation Board of Directors Current
Allergan, Inc. Senior Vice President Former
Female Health Care Group Product Director Former
The Pain Group Product Director Former
Kingston University Bsc (Hons) In Applied Chemistry and Business Studies Former
Organization Position Status
Allergan, Inc. Vice President Current

With over thirty years experience in the practice of food and drug law, Mr. Davis brings a unique perspective to his clients, having served both as in-house General Counsel and in private practice. Practicing initially with KKB in the 1970s and 1980s, he then spent 15 years in-house at Syntex and Allergan in California. Serving as General Counsel of several divisions of Allergan, he played a key roll in the regulatory approval, acquisition, development, launch, and highly successful marketing of BOTOX (botulinum toxin purified neurotoxin complex), as well as the development and licensing of several biologics manufacturing facilities for the product. At Allergan, he also managed the company's internal Institutional Review Board. He returned as a partner to KKB in 1998, opening the firm's West Coast office. In the professional arena, he has served as Vice Chair of the American Bar Association's Committee on Food and Drug Law. For many years, he was General Counsel of the Pharmaceutical Marketing Research Group. He has lectured on FDA law at numerous law schools and universities, including Stanford University, the University of the Pacific, and Saddleback Valley College.

Organization Position Status
Kkb & Company Partner, Managing Attorney, West Coast Office Current
Allergan, Inc. Partner Current
Allergan, Inc. General Counsel Former
Stanford University Former
Organization Position Status
Allergan, Inc. Senior Director, Marketing, Botox Current
Organization Position Status
Noblitt & Rueland Manager of Quality Assurance for the Information Services Current
Allergan, Inc. Manager Current
Organization Position Status
Allergan, Inc. Senior Vice President, Corp. Controller (Pao) Current
Allergan, Inc. Board of Directors Current
Allergan, Inc. Vice President & Controller Former
Organization Position Status
Allergan, Inc. Investigator Current
My Threadlift Clinical Assistant Professor of Plastic Surgery Current
Maryland Plastic & Cosmetic Surgery Clinical Assistant Professor Current
Mentor Corporation Investigator Current
University of Maryland Assistant Professor Current
Liposuction Surgeon Current
Southern California Plastic Surgery Current
All About Implants Current
St. Louis University School of Medicine Former
Organization Position Status
Allergan, Inc. Consultant Current
Botox Dentalsm Current
Tmd Courses Inc. Current
American Headache Society Board of Directors Current
The Headache Center Director Current
American Headache Society Member Current
University of the Witwatersrand Former
Organization Position Status
Calobrace Plastic Surgery Center Plastic Surgeon Current
Mentor Corporation Consultant Current
Allergan, Inc. Lecturer Current
Implantinfo Board Certified Plastic Surgeon In Louisville, Kentucky Current
Liposite Current
Implantinfo Board of Directors Current
American College of Surgeons Fellow Current
Indiana University School of Medicine Former

Irina Akkerman, FNP, MSN, Board Certified, LaserDoc Clinical Director, with more than 10 years of Laser Skin Care. Irina is a successful nurse practitioner with a masters in nursing science. She is a busy wife and mother of two children. An avid kick boxer, passionate believer in the power of exercise and positive energy. Irina is an expert in all forms of facial rejuvenation. She specalizes in correcting sun damaged skin and providing anti-aging skin and body care. She is expert in the use of Advanced FDA approved Pixel Fractional Resurfacing, Scar revisions, Harmony IPL Treatments, Laser Hair Removal, Accent XL Body and Face Treatments, Laser Leg Vein Therapy, Medical grade infusion system microdermabrasion, Acne treatement, Acne scar revision, and Preventive Skin Care Maintenance. LaserDoc is a premiere provider of Botox and Juvederm by Allergan. Irina is an Botox and Juvederm facial rejuvenation injection trainer for Allergan. As a leader in ALMA laser technology, we are certified laser trainers for ALMA Lasers. She is expert at tailoring our LaserDoc physician supervised Clinical Skin Care system to suit each individual and she will be your educator and guide during your Consultation and allow you to plan the aesthetic, health care and anti-aging goals you desire to achieve.

Organization Position Status
Allergan, Inc. Facial Rejuvenation Injection Trainer Current
The Laserdoc Skincare Center Board of Directors Current

As a published author, licensed pilot, and Registered Nurse, Jamie Sherrill is a woman of many talents. Upon first meeting her, her sense of humor and beauty belie her stature as cosmetic nurse to the stars in one of LA?s most elite medical spas. Pursued by medical spas across the country; however, exclusively employed by Belle Visage-- Nurse Jamie has performed countless injections, laser treatments and all forms of minor cosmetic surgeries both in her medical suite and on-site at the homes of the rich and famous. She believes she is doing her part to make the world a better place one hair and one wrinkle at a time. From housewives to A-list actresses, models to Hollywood?s leading men, Jamie?s scientific and research background has been tapped to provide an honest assessment of the latest trends, do?s and don?ts and red carpet secrets. In fact, Nurse Jamie has been sought after by every major media outlet for her cover girl looks, approachability and years of unparalleled expertise. She has the unique perspective of having watched the industry grow from its infancy to a multi-billion dollar business and coupled with her contagious enthusiasm, she has been tapped by shows such as Extra! Fashion Team, KTLA, Good Day LA and Queer Eye for the Straight Guy to give a sneak peek into the hidden world of celebrity cosmetic treatments. Encouraged by her celebrities clients and producers who recognized her natural on-camera persona, Jamie also began to pursue her love of acting, appearing in movies such as Dragonfly and a recurring roles as a nurse on Days of Our Lives, Untold Stories of the ER and most recently as a series regular on The Simple Life. Nurse Jamie entered the world of plastic surgery when she was handpicked for training as a teenager working for a plastic surgeon. Since beginning to perform treatments at a tender age, Jamie has been placed on the short list of go-to experts laser manufactures rely upon to test the latest technology and evangelize treatments to her high-profile clients. A pioneer in the industry, Jamie has also been chosen to lead multiple alpha test sites for laser manufacturers where she develops parameters for laser effectiveness, as well as safety usage guidelines for doctors. Jamie has over 10 years of injecting experience and is a trainer for CME Scholar/ Allergan?she trains others nurses and doctors on how to skillfully inject Botox and Juvederm. As the youngest of three girls raised on a farm in Southern Indiana who made her way to Beverly Hills, Nurse Jamie makes the world of Hollywood style accessible to everyone from stars to those who only read about it in the magazines. Additionally, she is author of Nurse Jamie?s Botox Diaries: Real Stories from a Fake World, a tell-all book that documents her medical spa experiences from the inspiring to the bizarre.

Organization Position Status
Allergan, Inc. Trainer Current
Nurse Jamie Current
Organization Position Status
Allergan, Inc. National Education Faculty Trainer Current
Lifebotanica Board of Directors Current
The Skin Cancer Foundation Board of Directors Former

Dr. Mark Ballentyne is a highly skilled physician who has been Director of Medical Aesthetics at the Skin Wellness Center for five years. He has established a strong reputation for his talent in performing the lip augmentation procedure, facial treatments with BOTOX Cosmetic injections and dermal fillers, photorejuvenation, sclerotherapy, medical level skin care treatments, and chemical peels. Dr. Ballentyne has helped many women and men achieve a more youthful appearance. His patients also benefit from Dr. Ballentyne's team approach to treatment, as he often collaborates with Dr. Lawrence N. Gray in caring for patients. In order to offer his patients the latest and safest treatments, Dr. Ballentyne attends various academic conferences, where he meets with other doctors to explore and discuss advances and innovations in aesthetic medicine. He has been invited to be a national trainer for Allergan , maker of some of the world's most popular dermal fillers, due to his technical skill, extensive experience, and eye for superior results. He is also frequently asked to demonstrate cosmetic injection methods to other doctors. A trait that sets Dr. Ballentyne apart from many other physicians is his ability to listen carefully to his patients, a skill he honed during his experience as a family practitioner. The attention he pays to his patients' goals and needs allows him to provide them with the highest possible quality of care.

Organization Position Status
Skin Wellness Center Director of Medical Aesthetics Current
Allergan, Inc. Trainer Current
Atlantic Plastic Surgery Center Board of Directors Current
Organization Position Status
Tulane University School of Medicine Clinical Professor Current
Allergan, Inc. Clinical Instructor Current
Dermik Instructor Current
Dr. Mary Lupo Skin Care Products, Inc. Current
Women's Dermatologic Society First, Year Board Representative Current
Women's Dermatologic Society President Former
Women's Dermatologic Society Vice President Former
Laser , Inc Program Director Former
Laser , Inc Faculty Member Former
Laser , Inc Board of Directors Former
Organization Position Status
Allergan, Inc. Assistant Secretary Current

Array

Organization Position Status
Plastic Surgical Arts Current
University of Nebraska - Lincoln Former

Array

Organization Position Status
Professional Skin Concepts Medspa Current

Dr. Thomas Kislan is the founder and medical director of Stroudsburg Eye Specialists (est. 1999), Hazleton Eye Specialists (est. 2001) and Dry Eye Clinic of Northeastern PA (est. 2002). These practices are large multi-disciplinary eye care facilities which provide routine medical eye care and the treatment and management of ocular diseases, such as cataracts, glaucoma, dry eye disease, diabetic retinopathy and macular degeneration. Dr. Kislan completed undergraduate study at Wilkes University and received his Doctor of Optometry from the Pennsylvania College of Optometry in Philadelphia. He completed internships at the Lynch Pediatric unit in Philadelphia, the Wilkes-Barre VA Medical Center and the Trachtenberg Moran Eye Surgery Center in Allentown, PA. Dr. Kislan is an educational lecturer and speaks nationally on Dry Eye Disease, Glaucoma, Ophthalmic use of Omega 3 Fatty Acids and the management of Refractive Surgery. Dr. Kislan participates in clinical research and has presented this research at many national meetings. This research has also been published in peer-reviewed journals. Dr. Kislan is a consultant for Allergan, AMO, Lifeguard Health and Pfizer pharmaceuticals. Dr. Kislan is also the host of Eye Care Today. This is a monthly show which airs on local Hazleton Channel 13 and is syndicated nationally on the web at ssptv.com. Dr. Kislan sees patients of all ages. He resides in Drums, PA with his wife, Dr. Sandra Krokos and their 5 year old son, Ryan. Dr. Kislan enjoys golf and traveling when he is not helping patients see better.

Organization Position Status
Allergan, Inc. Consultant Current
Lifeguard Health, LLC Consultant Current
Dr. Kislan Current
Organization Position Status
HLM Venture Partners Managing Partner Current
Allergan, Inc. Chairperson Current
Friends School of Baltimore Director Current
Friends' School Board of Directors Current
Somalogic Advisor To Board of Directors Current
Phreesia Director Current
Prism Education Group, Inc. Board of Directors Current
HLM Venture Partners President Former
Chesapeake Strategic Advisors, LLC President Former
Chesapeake Strategic Advisors, LLC Managing Director Former
HLM Venture Partners Managing Director Former
Chesapeake Strategic Advisors, LLC Founder Former
HLM Venture Partners Global Co-Head Former
Deutsche Bank AG Former
Wharton Graduate School of the University of Pennsylvania M.B.A. Degree In Finance Former
United States Military Academy B.S. Degree Former
University of Washington B.S. Degree In Zoology and Ecology Former
Organization Position Status
PhRMA Board Member Current
Millennium Pharmaceuticals, Inc. Director Current
The G&P Foundation for Cancer Research Board of Directors Current
Allergan, Inc. Director Current
Pharmaceutical Research and Manufacturers of America Board Member Current
Museum of Science Board Member Current
Cancercare Board Member Current
Millennium Pharmaceuticals, Inc. CEO Former
Millennium Pharmaceuticals, Inc. President Former
Novartis AG Senior Vice President Former
Novartis AG Vice President, Oncology Business Unit Former
Novartis AG Head of North American Oncology Operations Former
Sandoz Product Management, Scientific Development & Clinical Research Former
Rigid Building Systems Ltd. Former
University of the Witwatersrand Graduate of the Medical School Former
University Corp. Former

Array

Organization Position Status
Roger's Gardens Chairman Current
Doheny Eye Institute Board of Directors Current
University of Southern California Board of Directors Current
Allergan, Inc. Director Current
Allergan, Inc. Chief Executive Officer Former
Allergan, Inc. Founder Former
Doheny Eye Institute Director of Research Former
Prevent Blindness Director of Research Former
Southern California University Trustee Former
Allergan, Inc. Chairman Former
Organization Position Status
Genentech, Inc. Co Founder Current
University of California, San Francisco Professor of Biochemistry Current
Genentech, Inc. Board of Directors Current
Allergan, Inc. Vice Chairman Current
National Academy of Sciences Board of Directors Current
Allergan, Inc. Board of Directors Former
National Academy of Sciences Member Former
Organization Position Status
Great Lakes Chemical Corp Executive Vice President and Chief Financial Officer Current
Innophos, Inc Board of Directors Current
Sappi Limited Board of Directors Current
Allergan, Inc. Board of Directors Current
Webster Financial Corporation Board of Directors Current
Mead Corporation Chief Financial Officer Former
MeadWestvaco Corporation Chief Financial Officer Former
Chemtura Corporation Chief Financial Officer Former
Connecticut, Inc. Chief Financial Officer Former
Connecticut, Inc. Executive Vice President Former
Chemtura Corporation Executive Vice President Former
MeadWestvaco Corporation Senior Vice President Former
Tenneco, Inc. Vice President Former
Reable Therapeutics, Inc. Board of Directors Former
Tenneco, Inc. Treasurer Former
Chemtura Corporation Board of Directors Former
Columbia University M.B.A. In Finance Former
Smith College B.A. In Latin American Studies Former
Organization Position Status
WellPoint, Inc. Board of Directors Current
Amgen Inc. Board of Directors Current
Allergan, Inc. Director Current
Anthem Life Insurance Company Former
WellPoint, Inc. Chairman Former
Organization Position Status
BMC Software, Inc. Chairman Current
Equinix, Inc. Board of Directors Current
Allergan, Inc. Board of Directors Current
Kyphon, Inc. Board of Directors Current
Genentech, Inc. Chief Financial Officer Former
Genentech, Inc. Executive Vice President Former
Genentech, Inc. controller Former
Genentech, Inc. Chairman Former
BMC Software, Inc. Board of Directors Former
Arena Pharmaceuticals, Inc. Board of Directors Former
Temple University master's degree in business administration Former
Babson College bachelor's degree in business administration Former
Genentech, Inc. member Former
Organization Position Status
Beckman Instruments, Inc. Chairman Current
Allergan, Inc. Board of Directors Current
Beckman Instruments, Inc. Chief Executive Officer Former
Beckman Coulter, Inc. Chairman Emeritus Former
Organization Position Status
CEO Roundtable, LLC Founder Current
Hatteras Venture Partners General Partner Current
Sebio Current
OSI Pharmaceuticals, Inc. Chairman of the Board Current
Cvmanager Group Corporation Chairman of the Board Current
Hatteras Venture Partners Board of Directors Current
Nortel Networks Corporation Board of Directors Current
Allergan, Inc. Board of Directors Current
Rda-Summit, LLC. Vice Chairman, Pharmaceuticals Glaxosmithkline Current
Valeant Pharmaceuticals International Board of Directors Current
Cree, Inc. Vice Chairman Current
Edwards Lifesciences Corporation Board of Directors Current
Partnership for Public Service Vice Chairman Pharmaceuticals, Glaxosmithkline Current
Jennerex Biotherapeutics, Inc. Board of Directors Current
Cree, Inc. Board of Directors Current
GlaxoSmithKline Plc President Former
GlaxoSmithKline Plc Chief Operating Officer Former
Merck & Co. Inc. Vice President of Public Affairs Former
Corporate Governance Chairman Former
OSI Pharmaceuticals, Inc. Director Former
Eastern Illinois University B.S. Degree In Business Administration Former
Organization Position Status
Keck School of Medicine President Current
Doheny Eye Institute President Current
Allergan, Inc. Director Current
Ophthalmology, Ltd. President Former
The Macula Society President Former
University of Southern California Senior Vice President for Medical Care Former
University of Southern California Dean of the Keck School of Medicine Former
Southern California University Former
The Macula Society Member Former

Professor Trevor Jones CBE PhD DSc FKC FPS CChem FRSC MCPP FFPM has been Chairman of ReNeuron since February 1999. He recently retired as Director General of the Association of the British Pharmaceutical Industry (ABPI), the body representing the interests of some 100 national and international pharmaceutical companies. He was, until 1994, the Main Board Director responsible for Research and Development at Wellcome plc. He was responsible for the development of a number of significant new products at Wellcome, including Zovirax (anti-herpes), Retrovir (anti-HIV), Malarone (Malaria) and Lamictal (anti-epileptic). He is visiting professor, Deputy Chair of Council and Fellow of Kings College London, and is a member of the Board of Allergan Inc.

Organization Position Status
King's College London Visiting Professor Current
King's College Professor Current
TI Pharma Current
Ff&P Private Equity Limited Current
King's College London Deputy Chairman Current
Reneuron Group Plc Deputy Chairman Current
Javelin Ventures Limited Chairman Current
Synexus Ltd Chairman Current
People Inc. Chairman of the Board of Directors Current
People In Health Chairman Current
Ukscf Board of Directors Current
SciClone Pharmaceuticals, Inc. Board of Directors Current
Verona Pharma Plc Board of Directors Current
Allergan, Inc. Director Current
Libertas Capital Plc Board of Directors Current
Rhinopharma Ltd Board of Directors Current
King's College Vice-Chair Current
The Royal Society Fellow Current
British Pharmacological Society Fellow Current
Allergan, Inc. Member Current
Health-Corp Chairman of the Board Former
Abpi Director Former
University of London Ph.D. Former
University of Athens Honorary Doctorate Former
University of London Bachelor of Pharmacy Degree Former
Organization Position Status
LabOne, Inc. Current
First Responders Financial LLC Board of Directors Current
Quest Diagnostics Incorporated Board of Directors Current
Vasogen, Inc. Board of Directors Current
Massey Energy Company Board of Directors Current
Allergan, Inc. Board Member Current
Ocular Sciences, Inc. Board Member Current
MacKay-Shields Financial Corp. President Former
Smith Barney President Former
Galen Partners Co-founder Former
Advanced Medical Optics, Inc. Chairman Former
Vasogen, Inc. Chairman of the Board Former
MacKay-Shields Financial Corp. Chairman Former
Advanced Medical Optics, Inc. Director Former
Smith Barney Vice-Chairman Former
GlaxoSmithKline Plc Director Former
GlaxoSmithKline Plc Vice Chairman Former
Marion Laboratories Investor Former
American Hospital Supply Corporation Investor Former
SmithKline Beecham Corporation Investor Former

Executive News

  • Allergan Inc. (AGN) Receives FDA Approval for OZURDEX Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease

    BioSpace - 6/18/09 - View Story

  • Allergan Receives FDA Approval for Ozurdex Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease

    Pharma Live - 6/18/09 - View Story

  • Allergan Receives FDA Approval for OZURDEX(TM) Biodegradable, Injectable Steroid Implant with...

    Forbes.com - 6/18/09 - View Story

  • Allergan Receives FDA Approval for OZURDEX„ Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease

    Business Wire - 6/18/09 - View Story

  • Plump it up: longer, thicker eyelashes by prescription

    South China Morning Post - 6/15/09 - View Story

  • CORRECT: Takeda's Millennium Looking For Deals To Bolster Pipeline

    CNN Money - 6/02/09 - View Story

  • FDA Delays Approval of Allergan Inc. (AGN)'s Botox to Treat Spasticity

    BioSpace - 5/27/09 - View Story

  • Allergan Receives Complete Response Letter for BOTOX® (Botulinum Toxin Type A) for Treatment of Upper Limb Spasticity in Adults

    Reuters - 5/26/09 - View Story

  • Allergan Receives Complete Response Letter for BOTOX(R) (Botulinum Toxin Type A) for Treatment...

    Forbes.com - 5/26/09 - View Story

  • Allergan Receives Complete Response Letter for BOTOX (Botulinum Toxin Type A) for Treatment of Upper Limb Spasticity in Adults

    Business Wire - 5/26/09 - View Story

advertisement
     AGN $26.22 -21.23 (-44.74% )
Average Volume 2,225,240
Shares Outstanding 307.51M
Market Cap 8.1B
Year High 61.72
Year Low 25
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
advertisement